Anthera Pharmaceuticals Overview
- Founded
- 2004
- Status
- Public
- Employees
- 21
- Stock Symbol
- ANTH
- Share Price
- $0.03
- (As of Thursday Closing)
Anthera Pharmaceuticals General Information
Description
Anthera Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing and commercializing products to treat serious diseases associated with inflammation, including cardiovascular and autoimmune diseases. The company currently has one Phase 3-ready clinical program and two Phase 2 clinical programs. It was established in 2004.
Contact Information
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Stock Exchange
PINX
Primary Office
- 25801 Industrial Boulevard
- Suite B
- Hayward, CA 94545
- United States
+1 (510) 000-0000
Anthera Pharmaceuticals Stock Performance
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.03 | $0.03 | $0.02 - $0.07 | 64.3K |
Anthera Pharmaceuticals Financials Summary
|
In Thousands, USD |
TTM 31-Mar-2018 | FY 2017 31-Dec-2017 | FY 2016 31-Dec-2016 | FY 2015 31-Dec-2015 |
|---|---|---|---|---|
| EV | 5,610 | 17,109 | (1,648) | 129,260 |
| Revenue | 0 | 0 | 145 | 3,185 |
| EBITDA | (22,994) | (26,593) | (55,257) | (34,935) |
| Net Income | (23,391) | (26,874) | (55,523) | (35,220) |
| Total Assets | 8,811 | 3,673 | 23,471 | 48,125 |
| Total Debt | 0 | 0 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Anthera Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Anthera Pharmaceuticals‘s full profile, request access.
Request a free trialAnthera Pharmaceuticals Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Anthera Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing and commercializing products to tr
Biotechnology
Hayward, CA
21
As of 2017
00000
00000000
00000
00000 00
tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitati
000000000000000
Durham, NC
000
As of 0000
00000
000000 - 000
00000
00000000
la pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt moll
0000000000000
Charlottesville, VA
00
As of 0000
000.00
00000000
000.00
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialAnthera Pharmaceuticals Competitors (37)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Aerie Pharmaceuticals | Formerly VC-backed | Durham, NC | 000 | 00000 | 000000 - 000 | 00000 |
| 000000000 00000000 | Formerly VC-backed | Charlottesville, VA | 00 | 000.00 | 00000000 | 000.00 |
| 0000000 | Formerly VC-backed | Summit, NJ | 0000 | 000.00 | 000000&0 | 000.00 |
| 000000 | Formerly VC-backed | San Diego, CA | 00 | 000.00 | 000000&0 | 000.00 |
| 0000000 0000000000 | Corporate Backed or Acquired | South San Francisco, CA | 000 | 00000 | 000000&0 | 00000 |
Anthera Pharmaceuticals Executive Team (12)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Charles Olson | Co-Chief Technology Officer | ||
| May Liu | Chief Accounting Officer, Accounting & Senior Vice President |
Anthera Pharmaceuticals Board Members (14)
| Name | Representing | Role | Since |
|---|---|---|---|
| 00000 00000 | Self | Board Member | 000 0000 |
| 00000 0000000 | Self | Board Member | 000 0000 |
| 00000000000 000000 00.0 | Self | Board Member | 000 0000 |
| 00000 00000000 | Self | Board Member | 000 0000 |
| 0000 00000 | Anthera Pharmaceuticals | Chairman & Board Member | 000 0000 |
Anthera Pharmaceuticals Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialAnthera Pharmaceuticals Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
This information is available in the PitchBook Platform. To explore Anthera Pharmaceuticals‘s full profile, request access.
Request a free trial